A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

ConditionPTCL
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Eligibility criteria

Qualifiers

(1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.

Disqualifiers

(1) Patients with other types of lymphomas; (2) Pregnant women.

Trial design

Treatments tested in this trial

  • chidamide

Treatment groups

No treatment groups listed